NCT00352833View on ClinicalTrials.gov

Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

September 30, 2007

Conditions
Gastric CancerGastric Adenocarcinoma
Interventions
DRUG

catumaxomab

Trial Locations (1)

51109

Hospital of Cologne-Merheim, Surgical Department, Cologne

Sponsors

Lead Sponsor

Neovii Biotech
All Listed Sponsors
lead

Neovii Biotech

INDUSTRY

NCT00352833 - Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter